vs

Side-by-side financial comparison of FONAR CORP (FONR) and Maison Solutions Inc. (MSS). Click either name above to swap in a different company.

Maison Solutions Inc. is the larger business by last-quarter revenue ($27.6M vs $25.5M, roughly 1.1× FONAR CORP). FONAR CORP runs the higher net margin — 8.0% vs -18.0%, a 26.0% gap on every dollar of revenue. On growth, FONAR CORP posted the faster year-over-year revenue change (2.4% vs -10.9%). Over the past eight quarters, Maison Solutions Inc.'s revenue compounded faster (42.5% CAGR vs -0.3%).

FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.

Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.

FONR vs MSS — Head-to-Head

Bigger by revenue
MSS
MSS
1.1× larger
MSS
$27.6M
$25.5M
FONR
Growing faster (revenue YoY)
FONR
FONR
+13.3% gap
FONR
2.4%
-10.9%
MSS
Higher net margin
FONR
FONR
26.0% more per $
FONR
8.0%
-18.0%
MSS
Faster 2-yr revenue CAGR
MSS
MSS
Annualised
MSS
42.5%
-0.3%
FONR

Income Statement — Q2 FY2026 vs Q2 FY2026

Metric
FONR
FONR
MSS
MSS
Revenue
$25.5M
$27.6M
Net Profit
$2.1M
$-5.0M
Gross Margin
23.4%
Operating Margin
13.5%
-4.9%
Net Margin
8.0%
-18.0%
Revenue YoY
2.4%
-10.9%
Net Profit YoY
4.7%
-1840.5%
EPS (diluted)
$-0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FONR
FONR
MSS
MSS
Q4 25
$25.5M
$27.6M
Q3 25
$26.0M
$27.2M
Q2 25
$27.3M
$34.4M
Q1 25
$27.2M
$32.3M
Q4 24
$24.9M
$29.4M
Q3 24
$25.0M
$28.2M
Q2 24
$25.9M
$16.9M
Q1 24
$25.7M
$13.6M
Net Profit
FONR
FONR
MSS
MSS
Q4 25
$2.1M
$-5.0M
Q3 25
$2.3M
$-1.5M
Q2 25
$729.3K
$-287.4K
Q1 25
$2.5M
$1.0M
Q4 24
$2.0M
$-256.0K
Q3 24
$3.1M
$700.9K
Q2 24
$830.4K
$-2.8M
Q1 24
$1.9M
$-549.0K
Gross Margin
FONR
FONR
MSS
MSS
Q4 25
23.4%
Q3 25
24.1%
Q2 25
9.5%
Q1 25
21.8%
Q4 24
26.9%
Q3 24
28.9%
Q2 24
13.0%
Q1 24
23.4%
Operating Margin
FONR
FONR
MSS
MSS
Q4 25
13.5%
-4.9%
Q3 25
14.1%
0.7%
Q2 25
5.3%
-15.9%
Q1 25
15.2%
3.7%
Q4 24
11.9%
3.2%
Q3 24
21.0%
7.3%
Q2 24
7.4%
-14.4%
Q1 24
16.8%
-2.3%
Net Margin
FONR
FONR
MSS
MSS
Q4 25
8.0%
-18.0%
Q3 25
8.7%
-5.7%
Q2 25
2.7%
-0.8%
Q1 25
9.2%
3.1%
Q4 24
7.9%
-0.9%
Q3 24
12.6%
2.5%
Q2 24
3.2%
-16.4%
Q1 24
7.3%
-4.0%
EPS (diluted)
FONR
FONR
MSS
MSS
Q4 25
$-0.23
Q3 25
$-0.08
Q2 25
$-0.02
Q1 25
$0.06
Q4 24
$-0.01
Q3 24
$0.04
Q2 24
$-0.16
Q1 24
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FONR
FONR
MSS
MSS
Cash + ST InvestmentsLiquidity on hand
$121.0K
Total DebtLower is stronger
$2.6M
Stockholders' EquityBook value
$176.9M
$11.6M
Total Assets
$217.2M
$75.4M
Debt / EquityLower = less leverage
0.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FONR
FONR
MSS
MSS
Q4 25
$121.0K
Q3 25
$122.0K
$1.1M
Q2 25
$56.5M
$775.4K
Q1 25
$123.0K
$445.4K
Q4 24
$121.0K
$355.7K
Q3 24
$136.0K
$588.9K
Q2 24
$56.5M
$2.1M
Q1 24
$134.0K
$9.4M
Total Debt
FONR
FONR
MSS
MSS
Q4 25
$2.6M
Q3 25
$2.6M
Q2 25
$2.6M
Q1 25
Q4 24
Q3 24
$2.5M
Q2 24
$66.9K
$2.6M
Q1 24
$2.6M
Stockholders' Equity
FONR
FONR
MSS
MSS
Q4 25
$176.9M
$11.6M
Q3 25
$174.9M
$10.1M
Q2 25
$172.6M
$11.7M
Q1 25
$171.9M
$12.0M
Q4 24
$169.8M
$10.9M
Q3 24
$168.7M
$11.2M
Q2 24
$166.0M
$10.5M
Q1 24
$165.8M
$13.3M
Total Assets
FONR
FONR
MSS
MSS
Q4 25
$217.2M
$75.4M
Q3 25
$218.4M
$73.3M
Q2 25
$216.9M
$77.4M
Q1 25
$214.9M
$82.7M
Q4 24
$208.0M
$82.7M
Q3 24
$212.3M
$82.1M
Q2 24
$214.2M
$82.4M
Q1 24
$209.6M
$44.2M
Debt / Equity
FONR
FONR
MSS
MSS
Q4 25
0.22×
Q3 25
0.26×
Q2 25
0.22×
Q1 25
Q4 24
Q3 24
0.23×
Q2 24
0.00×
0.24×
Q1 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FONR
FONR
MSS
MSS
Operating Cash FlowLast quarter
$171.0K
$-1.7M
Free Cash FlowOCF − Capex
$-227.0K
FCF MarginFCF / Revenue
-0.9%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
0.08×
TTM Free Cash FlowTrailing 4 quarters
$5.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FONR
FONR
MSS
MSS
Q4 25
$171.0K
$-1.7M
Q3 25
$1.7M
$1.1M
Q2 25
$4.2M
$-1.6M
Q1 25
$3.1M
$1.7M
Q4 24
$2.2M
$1.1M
Q3 24
$1.7M
$3.6M
Q2 24
$4.6M
$-2.6M
Q1 24
$2.8M
$-1.4M
Free Cash Flow
FONR
FONR
MSS
MSS
Q4 25
$-227.0K
Q3 25
$-177.0K
Q2 25
$3.6M
Q1 25
$2.6M
Q4 24
$1.5M
Q3 24
$-148.0K
Q2 24
$4.2M
Q1 24
$2.6M
FCF Margin
FONR
FONR
MSS
MSS
Q4 25
-0.9%
Q3 25
-0.7%
Q2 25
13.1%
Q1 25
9.4%
Q4 24
6.0%
Q3 24
-0.6%
Q2 24
16.1%
Q1 24
10.2%
Capex Intensity
FONR
FONR
MSS
MSS
Q4 25
1.6%
Q3 25
7.2%
Q2 25
2.4%
Q1 25
2.2%
Q4 24
3.0%
Q3 24
7.2%
Q2 24
1.6%
Q1 24
0.7%
Cash Conversion
FONR
FONR
MSS
MSS
Q4 25
0.08×
Q3 25
0.75×
Q2 25
5.79×
Q1 25
1.26×
1.66×
Q4 24
1.14×
Q3 24
0.53×
5.12×
Q2 24
5.54×
Q1 24
1.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FONR
FONR

Managementof Diagnostic Imaging Centers$23.2M91%
Manufacturingand Servicingof Medical Equipment$2.4M9%

MSS
MSS

Perishables$14.4M52%
Nonperishables$13.2M48%

Related Comparisons